These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2261346)

  • 1. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
    Hann IM; Eden OB; Barnes J; Pinkerton CR
    Br J Haematol; 1990 Nov; 76(3):359-64. PubMed ID: 2261346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
    Patte C; Auperin A; Gerrard M; Michon J; Pinkerton R; Sposto R; Weston C; Raphael M; Perkins SL; McCarthy K; Cairo MS;
    Blood; 2007 Apr; 109(7):2773-80. PubMed ID: 17132719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
    Termuhlen AM; Smith LM; Perkins SL; Lones M; Finlay JL; Weinstein H; Gross TG; Abromowitch M
    Pediatr Blood Cancer; 2012 Dec; 59(7):1229-33. PubMed ID: 22488718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical characteristics and outcomes of 16 Burkitt' s lymphoma with testicular involvement].
    Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
    Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):768-773. PubMed ID: 27719719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
    Gupta S; Teachey DT; Chen Z; Rabin KR; Dunsmore KP; Larsen EC; Maloney KW; Mattano LA; Winter SS; Carroll AJ; Heerema NA; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Winick NJ; Loh ML; Hunger SP; Devidas M
    Cancer; 2022 May; 128(9):1863-1870. PubMed ID: 35201611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
    De Moerloose B; Suciu S; Bertrand Y; Mazingue F; Robert A; Uyttebroeck A; Yakouben K; Ferster A; Margueritte G; Lutz P; Munzer M; Sirvent N; Norton L; Boutard P; Plantaz D; Millot F; Philippet P; Baila L; Benoit Y; Otten J;
    Blood; 2010 Jul; 116(1):36-44. PubMed ID: 20407035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab.
    Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
    Chin Med J (Engl); 2021 Mar; 134(11):1329-1334. PubMed ID: 33734131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
    Gossai NP; Devidas M; Chen Z; Wood BL; Zweidler-McKay PA; Rabin KR; Loh ML; Raetz EA; Winick NJ; Burke MJ; Carroll AJ; Esiashvili N; Heerema NA; Carroll WL; Hunger SP; Dunsmore KP; Winter SS; Teachey DT
    Blood; 2023 Apr; 141(15):1802-1811. PubMed ID: 36603187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of rituximab in children and adolescents with mature B-cell non-Hodgkin's lymphoma: a Meta analysis].
    Li BY; Han YH; Yin CY; DU WC; Li YF; Wang YC
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):51-59. PubMed ID: 36655664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for recurrence of childhood acute lymphoblastic leukemia after treatment with the Chinese Children's Cancer Group ALL-2015 protocol].
    Chen X; Lei XY; Guan XM; Dou Y; Wen XH; Guo YX; Gao HQ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jul; 26(7):701-707. PubMed ID: 39014946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor B-cell Lymphoblastic Lymphoma in Children: Hacettepe Experience.
    Susam-Sen H; Yalcin B; Orhan D; Aydin B; Kurucu N; Varan A; Uner A; Kutluk T
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e746-e749. PubMed ID: 36898054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dosage of rituximab for children with Burkitt lymphoma.
    Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
    Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.
    Al Sbihi A; Manasrah N; Sano D; Lonardo S
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33879463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
    Gaietto A; Panetta JC; Pauley JL; Relling MV; Ribeiro R; Ehrhardt MJ; Pui CH; Inaba H; Swanson HD
    Cancer Chemother Pharmacol; 2024 Jun; 93(6):617-625. PubMed ID: 38416167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended vincristine and dexamethasone pulse therapy may not be necessary for children with TCF3-PBX1 positive acute lymphoblastic leukaemia.
    Wan Y; Zhang H; Zhang L; Cai J; Yu J; Hu S; Fang Y; Gao J; Jiang H; Yang M; Liang C; Jin R; Tian X; Ju X; Hu Q; Jiang H; Li H; Wang N; Sun L; Leung AWK; Wu X; Wang J; Li CK; Yang J; Tang J; Shen S; Zhai X; Pui CH; Zhu X
    Br J Haematol; 2022 Nov; 199(4):587-596. PubMed ID: 36114009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and outcomes of digestive tract perforation in pediatric mature B-cell non-Hodgkin lymphoma].
    Yang XL; Liu TT; Wang XM; Lyu ZK; Jin L; Yang J; Huang S; Zhang M; Li N; Yan JY; Duan YL
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(27):2568-2571. PubMed ID: 38978383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory Burkitt Lymphoma Following Acute Lymphoblastic Leukemia in a Patient with Homozygous
    Genç DB; Yıldırmak ZY; Elli M; Ayaz A; Ton Ö
    Turk J Haematol; 2024 May; 41(2):126-127. PubMed ID: 38426299
    [No Abstract]   [Full Text] [Related]  

  • 18. Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon.
    Hesseling PB; Afungchwi GM; Njodzeka BW; Wharin P; Kouya FN; Kruger M
    PLoS One; 2024; 19(3):e0299777. PubMed ID: 38466670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
    Raetz EA; Bhojwani D; Devidas M; Gore L; Rabin KR; Tasian SK; Teachey DT; Loh ML
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30585. PubMed ID: 37489549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.
    Rizzieri DA; Johnson JL; Byrd JC; Lozanski G; Blum KA; Powell BL; Shea TC; Nattam S; Hoke E; Cheson BD; Larson RA;
    Br J Haematol; 2014 Apr; 165(1):102-11. PubMed ID: 24428673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.